Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine.
Pederson S, Biondi DM, Allan B, Cady R, Schaeffler B, Baker B, Latham J. Pederson S, et al. Among authors: schaeffler b. Front Immunol. 2021 Oct 25;12:765822. doi: 10.3389/fimmu.2021.765822. eCollection 2021. Front Immunol. 2021. PMID: 34759933 Free PMC article. Clinical Trial.
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.
Silberstein S, Diamond M, Hindiyeh NA, Biondi DM, Cady R, Hirman J, Allan B, Pederson S, Schaeffler B, Smith J. Silberstein S, et al. Among authors: schaeffler b. J Headache Pain. 2020 Oct 6;21(1):120. doi: 10.1186/s10194-020-01186-3. J Headache Pain. 2020. PMID: 33023473 Free PMC article. Clinical Trial.
Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients.
Baker B, Schaeffler B, Hirman J, Hompesch M, Pederson S, Smith J. Baker B, et al. Among authors: schaeffler b. Endocrinol Diabetes Metab. 2021 Feb 2;4(2):e00217. doi: 10.1002/edm2.217. eCollection 2021 Apr. Endocrinol Diabetes Metab. 2021. PMID: 33855218 Free PMC article. Clinical Trial.
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.
Lipton RB, Goadsby PJ, Smith J, Schaeffler BA, Biondi DM, Hirman J, Pederson S, Allan B, Cady R. Lipton RB, et al. Among authors: schaeffler ba. Neurology. 2020 Mar 31;94(13):e1365-e1377. doi: 10.1212/WNL.0000000000009169. Epub 2020 Mar 24. Neurology. 2020. PMID: 32209650 Free PMC article. Clinical Trial.
Corrigendum to "Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study" [Clin Therapeut 42 (12) (2020) 2254-2265].
Smith TR, Janelidze M, Chakhava G, Cady R, Hirman J, Allan B, Pederson S, Smith J, Schaeffler B. Smith TR, et al. Among authors: schaeffler b. Clin Ther. 2021 Apr;43(4):791. doi: 10.1016/j.clinthera.2021.01.019. Epub 2021 Apr 1. Clin Ther. 2021. PMID: 33814199 No abstract available.
12 results